Objectives: Concerns on climate change are leading to the renaissance of wood burning and particulate exposures. Levo glucosan is used as a marker of woodsmoke in air and urine. Objectives: Contribution of data on urinary excretion of levo glucosan, to improve biomonitoring and source apportionment of woodsmoke. Materials and Methods: 1, 3, 5, and 7 hours after 5 mg of levoglucosan had been administered orally, urinary excretion was measured by HPLC and mass spectrometry. Results: After oral intake, urine concentrations increased rapidly, reached highest values after 3 hours, and after 7 hours approximately 70% of the administered dose was excreted. Conclusions: Urinary levoglucosan may be used for biomoni toring of woodsmoke exposure on the same day.
Key words: Woodsmoke Biomonitoring, Levoglucosan, Human urine, ExcretionThe authors declare that the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Ethics Com mittee, Medical University of Vienna) and with the Helsinki Declaration of 1975, as revised in 1983. The authors Hanns Moshammer (HM) and Manfred Neuberger (MN) experimented on themselves with a low dose, comparable to involuntary environmental exposure, and asked Stefan Weiss to analyze the excretion in their urine. HM and MN are independent and fully informed researchers.